FEATURED TOP LISTS Follow us on twitter
AppAdvice AppAdvice/TV WatchAware

"LIFE - The Losartan Intervention For Endpoint reduction in Hypertension Study is an easy to use publication finder and reader

LIFE Trial

by Merck Sharp & Dohme Corp.

What is it about?

"LIFE - The Losartan Intervention For Endpoint reduction in Hypertension Study is an easy to use publication finder and reader. This app allows hysicians/Medical Practitioners/Researchers to access journal abstracts/publications for free. There are hundreds of publications are allowed to search and explore. It provides selected article from the journal like J Hum Hypertens, Curr Cardiol Rep,Am J Cardiovasc Drugs. AM Heart J and many more. This app provides search facilities based on cutom keywords as well along with the listed keywords i.e. Hypertenstion, HTN Losartan etc.

App Details

Version
1.0
Rating
NA
Size
25Mb
Genre
医疗 教育
Last updated
October 18, 2017
Release date
October 18, 2017
More info

App Store Description

"LIFE - The Losartan Intervention For Endpoint reduction in Hypertension Study is an easy to use publication finder and reader. This app allows hysicians/Medical Practitioners/Researchers to access journal abstracts/publications for free. There are hundreds of publications are allowed to search and explore. It provides selected article from the journal like J Hum Hypertens, Curr Cardiol Rep,Am J Cardiovasc Drugs. AM Heart J and many more. This app provides search facilities based on cutom keywords as well along with the listed keywords i.e. Hypertenstion, HTN Losartan etc.
Privacy policy: http://www.msd.com/privacy/
Contact
1-267-305-0333
If you are a healthcare professional in the U.S., call:
1-800-339-0400"

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.